# OnCo record car-t-bridging (protocol). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/protocols/car-t-bridging/>
  a schema:MedicalGuideline ;
  onco:kind "protocol" ;
  schema:identifier "car-t-bridging" ;
  schema:name "Bridging therapy while CAR T cells are manufactured"@en ;
  schema:alternateName "bridging therapy"@en, "CAR-T bridging"@en, "bridging chemotherapy"@en, "holding therapy before CAR T"@en, "bridging radiotherapy"@en ;
  schema:description "Making CAR T cells from your own blood takes several weeks. During that wait many people have a short course of treatment, called bridging, to keep the cancer under control so they are well enough for the CAR T cells. It is given only after the blood cells have been collected, and is chosen so it will not cause infections or organ problems that could delay the infusion."@en ;
  schema:url <https://onco.cc/protocols/car-t-bridging/> ;
  schema:dateModified "2026-11-11"^^xsd:date ;
  onco:tag "protocol", "cell-therapy", "car-t" ;
  onco:related <https://onco.cc/protocols/car-t-apheresis/>, <https://onco.cc/protocols/car-t-lymphodepletion/> ;
  onco:cancers <https://onco.cc/cancers/dlbcl/>, <https://onco.cc/cancers/primary-mediastinal-b-cell-lymphoma/>, <https://onco.cc/cancers/mantle-cell-lymphoma/>, <https://onco.cc/cancers/follicular-lymphoma/>, <https://onco.cc/cancers/all-leukemia/>, <https://onco.cc/cancers/multiple-myeloma/> ;
  onco:technologies <https://onco.cc/technologies/car-t/> ;
  onco:drugs <https://onco.cc/drugs/rituximab/>, <https://onco.cc/drugs/gemcitabine/>, <https://onco.cc/drugs/oxaliplatin/>, <https://onco.cc/drugs/bendamustine/>, <https://onco.cc/drugs/pixantrone/>, <https://onco.cc/drugs/cyclophosphamide/>, <https://onco.cc/drugs/etoposide/>, <https://onco.cc/drugs/procarbazine/>, <https://onco.cc/drugs/lenalidomide/>, <https://onco.cc/drugs/ibrutinib/>, <https://onco.cc/drugs/dexamethasone/>, <https://onco.cc/drugs/methylprednisolone/>, <https://onco.cc/drugs/talquetamab/>, <https://onco.cc/drugs/venetoclax/>, <https://onco.cc/drugs/carfilzomib/>, <https://onco.cc/drugs/pomalidomide/> ;
  onco:terms <https://onco.cc/terms/bridging-therapy/>, <https://onco.cc/terms/lymphoma-tx-car-t-pathway/> .